Varian plans to integrate intelligent therapeutic technologies and image-guided innovations into a unified platform. Credit: MAD.vertise / Shutterstock.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Varian’s IntelliBlate microwave ablation system, designed for soft tissue ablation.

The system is engineered to offer clinicians increased predictability, precision, and control during ablation procedures. It creates large, controlled spherical ablation zones, ensuring predictable treatment outcomes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system’s flexibility is highlighted by its dual probe capability, with each probe featuring either linked or independent controls to cater to individual patient needs.

Further enhancing the system’s precision is the Ximitry probe, which introduces advanced features such as LED indicators and laser disk alignment.

The IntelliBlate system’s compact and versatile design, coupled with an intuitive interface, provides a flexible solution that simplifies the adoption of microwave ablation.

Looking ahead, Varian, a Siemens Healthineers company, plans to integrate intelligent therapeutic technologies and image-guided innovations into a unified platform.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The integration aims to offer clinicians enhanced predictability in probe placement, treatment delivery, and procedural confirmation.

Varian Interventional Solutions vice-president and chief medical officer Dr David Hahn said: “IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation.

“This innovative system brings new versatility in treatment options, fueling clinician-driven innovation to tackle a wide variety of cases. Real-time monitoring and treatment information at the tissue level aim to further empower care teams with the confidence to deliver highly personalised care to patients.”

In partnership with Siemens Healthineers, Varian continues to invest in the development of integrated microwave ablation technologies that combine therapy and image-guided solutions.